Considering this and because of the clinical impact of MYC R, we sought to develop artificial intelligence (AI) systems composed of recurrent cytogenetic aberrations (RCAs) and derived genetic progression score (GPS) to predict MYC+ DLBCL tumors. Here, MYC is linked to diffuse large B-cell lymphoma.